A | THE MOST NOTABLE EXAMPLES ARE THE MEDICAL DEVICE INNOVATION CONSORTIUM AND TRANSCELERATE. Both are nonprofit organizations that bring together representatives from industry, government, nonprofits, and patient groups to advance patient access to novel medical technologies and drug therapies. Specifically, they focus on improving processes for development, methods, and resources used in managing the product life cycle. Other consortia are narrowly focused, e.g., International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), World Intellectual Property Organization (WIPO) Re:Search, Intelligence-Led Assessment of Pharmaceuticals in the Environment (iPIE), Enabling Technologies Consortium (ETC), and The Critical Path for Parkinson’s Consortium, among others. Lastly, state life sciences industry associations have formed consortia: the State MedTech Alliance (coordinated with AdvaMed), the Regional MedTech Alliance (under auspices of Medical Device Manufacturers Association), and most prominently, the Council of State Bioscience Associations (under Biotechnology Innovation Organization). Collectively, they promote public understanding and advocate for public policies that support the responsible development of the biosciences industry.
STEPHEN RAPUNDALO, PH.D.,president and CEO of MichBio, is an established biosciences business and policy leader. A former elected official, Rapundalo has 20 years of pharmaceutical industry experience.